CYP2C19 GENOTYPING Test
Test Name: CYP2C19 GENOTYPING Test
Components: CYP2C19 gene analysis
Price: 1850.0 AED
Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery: SampleSat by 11 am; Report 15 Working days
Method: PCR, Sequencing
Test type: Pharmacogenomics
Doctor: Physician
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
What is the CYP2C19 genotyping test?
The CYP2C19 genotyping test is a genetic test that determines an individual’s specific genetic variations in the CYP2C19 gene. This gene encodes an enzyme that is responsible for metabolizing various drugs, including antiplatelet agents, antidepressants, and proton pump inhibitors.
Why is the test performed?
The test is usually performed to identify individuals who may have variations in the CYP2C19 gene, which can affect how they metabolize certain medications. These genetic variations can result in either decreased or increased enzyme activity, leading to variations in drug response and potential adverse effects.
How is the test conducted?
The CYP2C19 genotyping test is typically done using a sample of blood or saliva. The sample is then analyzed in a laboratory to identify specific genetic variations in the CYP2C19 gene.
Benefits of the test
The results of the test can help healthcare providers personalize medication dosages and treatment plans based on an individual’s genetic profile. The test is particularly important for medications with a narrow therapeutic index, where small changes in drug metabolism can significantly impact treatment outcomes. It can also be useful in identifying individuals who may be at an increased risk of adverse drug reactions or treatment failure.
Who should consider the test?
It is important to note that the CYP2C19 genotyping test is not routinely performed on everyone. It is typically reserved for individuals who are receiving or are about to receive medications that are known to be metabolized by the CYP2C19 enzyme. The test results should be interpreted by a healthcare professional who can take into account the individual’s medical history, other medications being taken, and other relevant factors.
| Test Name | CYP2C19 GENOTYPING Test |
|---|---|
| Components | |
| Price | 1850.0 AED |
| Sample Condition | 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Report Delivery | SampleSat by 11 am;Report 15 Working days |
| Method | PCR, Sequencing |
| Test type | Pharmacogenomics |
| Doctor | Physician |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Test Details | CYP2C19 genotyping test is a genetic test that determines an individual’s specific genetic variations in the CYP2C19 gene. This gene encodes an enzyme that is responsible for metabolizing various drugs, including antiplatelet agents, antidepressants, and proton pump inhibitors. The test is usually performed to identify individuals who may have variations in the CYP2C19 gene, which can affect how they metabolize certain medications. These genetic variations can result in either decreased or increased enzyme activity, leading to variations in drug response and potential adverse effects. The CYP2C19 genotyping test is typically done using a sample of blood or saliva. The sample is then analyzed in a laboratory to identify specific genetic variations in the CYP2C19 gene. The results of the test can help healthcare providers personalize medication dosages and treatment plans based on an individual’s genetic profile. The test is particularly important for medications with a narrow therapeutic index, where small changes in drug metabolism can significantly impact treatment outcomes. It can also be useful in identifying individuals who may be at an increased risk of adverse drug reactions or treatment failure. It is important to note that the CYP2C19 genotyping test is not routinely performed on everyone. It is typically reserved for individuals who are receiving or are about to receive medications that are known to be metabolized by the CYP2C19 enzyme. The test results should be interpreted by a healthcare professional who can take into account the individual’s medical history, other medications being taken, and other relevant factors. |
